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Abstract
In the last decade, genome sequence data and gene
structure information on invertebrate receptors has
been greatly expanded by large sequencing pro-
jects and cloning studies. This information is of great
value for the identification of receptors; however,
functional and pharmacological data are necessary
for an accurate receptor classification and for practi-
cal applications. In insects, an important group of
neurotransmitter and neurohormone receptors, for
which ample sequence information is available but
pharmacological information is missing, are the
biogenic amine G protein-coupled receptors (GPCRs).
In the present study, we investigated the sequence
information, pharmacology and signalling properties
of a 5-HT7-type serotonin receptor from the red flour
beetle, Tribolium castaneum (Trica5-HT7). The recep-
tor encoding cDNA shows considerable sequence
similarity with cognate 5-HT7 receptors and phylo-
genetic analysis also clusters the receptor within this
5-HT receptor group. Real-time reverse transcription
PCR demonstrated high expression levels in the
brain, indicating the possible importance of this
receptor in neural processes. Trica5-HT7 was dose-
dependently activated by 5-HT, which induced
elevated intracellular cyclic AMP levels but had no
effect on calcium signalling. The synthetic agonists,
α-methyl 5-HT, 5-methoxytryptamine, 5-carboxami-
dotryptamine and 8-hydroxy-2-(dipropylamino)tetralin
hydrobromide, showed a response, although with
a much lower potency and efficacy than 5-HT.
Ketanserin and methiothepin were the most potent
antagonists. Both showed characteristics of competi-
tive inhibition on Trica5-HT7. The signalling pathway
and pharmacological profile offer important informa-
tion that will facilitate functional and comparative
studies of 5-HT receptors in insects and other inver-
tebrates. The pharmacology of invertebrate 5-HT
receptors differs considerably from that of verte-
brates. The present study may therefore contribute to
establishing a more reliable classification of inver-
tebrate 5-HT receptors.
Keywords: biogenic amine, cyclic AMP, G protein-
coupled receptor (GPCR), insect, pharmacology, red
flour beetle.
Introduction
The red flour beetle, Tribolium castaneum, is known world-
wide as a pest insect of stored products and, in recent
years, it gained increasing interest as a model organism.
It belongs to the order of Coleoptera, which is the largest
and most species-diverse of all known metazoan orders.
T. castaneum also serves as a research model for other
(holometabolous) insects, contributing to the comparative
study of genetic, developmental and physiological
changes during evolution. The genome of T. castaneum
was sequenced during 2004–2006 and its analysis was
published in 2008 (Tribolium Genome Sequencing
Consortium, 2008).
With more insect genomes becoming available, general
features and differences between these genomes can be
studied with increasing detail. One of the largest catego-
ries of proteins encoded in these genomes are the G
protein-coupled receptors (GPCRs), which play a promi-
nent role in many essential signalling pathways through-
out the animal kingdom. A subgroup of these receptors are
the biogenic amine GPCRs. For Drosophila melanogaster
(Brody & Cravchik, 2000; Vanden Broeck, 2001; Hauser
et al., 2006, 2008), Apis mellifera (Hauser et al., 2006),
Correspondence: Jozef Vanden Broeck, Zoological Institute, Naamsestraat
59 box 2465, 3000 Leuven, Belgium. Tel.: + 32 16 324260; fax: + 32 16
323902; e-mail: jozef.vandenbroeck@bio.kuleuven.be
bs_bs_banner
Insect
Molecular
Biology
Insect Molecular Biology (2013) doi: 10.1111/imb.12076
© 2013 Royal Entomological Society 1
Anopheles gambiae (Hill et al., 2002) and Bombyx mori
(Fan et al., 2010), respectively 21, 19, 18 and 16 biogenic
amine GPCRs were predicted. In T. castaneum 20
biogenic amine GPCRs are predicted (Hauser et al.,
2008; Bai et al., 2011). In all metazoans, biogenic amines
play a crucial role in many key processes. In insects, five
major amines are involved in intercellular signalling: sero-
tonin (5-hydroxytryptamine, 5-HT), dopamine, histamine,
octopamine and tyramine. Serotonin is a monoamine neu-
rotransmitter, known for its role in the regulation of many
important human processes, such as mood and emotion,
sleep, appetite, pain, sexual activity and learning abilities.
In several insect species, similar processes were shown to
be influenced by 5-HT, including sleep and circadian
rhythms, nutrition, behaviour, development, learning
and memory formation (Berridge & Patel, 1968; Trimmer,
1985; Cohen et al., 1988; Adachi et al., 1989; Chiang
et al., 1992; Colas et al., 1995; Novak et al., 1995; Yuan
et al., 2005, 2006; Walz et al., 2006; Dierick & Greenspan,
2007; Sitaraman et al., 2008, 2012; Anstey et al., 2009;
Thamm et al., 2010; Ott et al., 2012).
Searches for receptor genes in publicly available
genome databases are merely based on sequence infor-
mation, which can provide indications for receptor classi-
fication and comparison; however, sequence data do not
allow a very accurate prediction of the pharmacological
and signalling properties or functional characteristics of
these receptors. In insects, high sequence similarity has
been observed between 5-HT receptors from different
species, but still very little is known about their pharma-
cology and signalling cascade. This information is of great
importance for functional studies. In addition, it would be
very useful to examine the evolution of 5-HT receptors. All
this information would contribute to proper invertebrate
5-HT receptor classification. Indeed, vertebrate 5-HT
receptors have a clear classification based on sequence
similarities, gene organization, second messenger cou-
pling and pharmacological properties. They are divided
into seven main classes. Six of these are GPCRs and
the sole exception, 5-HT3, is a ligand-gated ion channel.
Several of these main receptor types probably result from
ancient gene duplications in the common ancestor of ver-
tebrates and invertebrates, therefore, this general classi-
fication has thus far been employed for invertebrate 5-HT
receptors as well. Based on sequence similarities with
vertebrate receptors, the insect receptors can all be clas-
sified as 5-HT1-, 5-HT2- and 5-HT7-type GPCRs. Within
the same receptor type, the signalling properties seem
to be very well conserved between invertebrates and
vertebrates, but their pharmacological characteristics
may differ significantly (Tierney, 2001). In the genome of
T. castaneum, four 5-HT receptors are predicted: two
5-HT1 receptors and one 5-HT2 and 5-HT7 receptor
(Hauser et al., 2008). Only one Trica5-HT1 receptor has
been characterized extensively (Vleugels et al., 2013).
Orthologues of these four 5-HT receptors were character-
ized in D. melanogaster for some time. In addition, the
existence of a second 5-HT2 receptor had been sug-
gested (Clark et al., 2004; Blenau & Thamm, 2011) and
was recently confirmed experimentally (Gasque et al.,
2013). In A. mellifera, two 5-HT2 receptors are predicted
as well, but only one 5-HT1 and 5-HT7 receptor were
characterized (Witz et al., 1990; Saudou et al., 1992;
Colas et al., 1995; Schlenstedt et al., 2006; Thamm et al.,
2010).
The present study describes a pharmacological study of
a 5-HT7 receptor of T. castaneum, and the elucidation of
its second messenger signalling. 5-HT7-type serotonin
receptors are characterized by positive coupling to cyclic
AMP (cAMP) via binding to Gs proteins. Initial cloning of
the human and rat 5-HT7 receptor was published in 1993
by several laboratories independently (Bard et al., 1993;
Lovenberg et al., 1993; Ruat et al., 1993; Shen et al.,
1993). In insects, 5-HT7 receptors were identified and
pharmacologically characterized in D. melanogaster (Witz
et al., 1990), A. mellifera (Schlenstedt et al., 2006), Aedes
aegypti (Pietrantonio et al., 2001; Lee & Pietrantonio,
2003) and Calliphora vicina (Roser et al., 2012); however,
no general consensus pharmacological profile could be
composed from these studies, indicating the importance
of more profound and detailed characterization studies of
other insect (or other invertebrate) 5-HT receptors. The
aim of the present study was to gain pharmacological and
signalling information, in addition to the existing sequence
information, concerning the 5-HT7-type receptor of T.
castaneum. These data will be important for generating
a more detailed pharmacological classification system of
insect 5-HT receptors and could be used in future func-
tional assays and in practical applications.
Results and discussion
Receptor sequence and phylogenetic analysis
of Trica-5-HT7
The full-length sequence encoding a 5-HT7-type receptor
of T. castaneum, named Trica5-HT7, was amplified from
whole body cDNA. The open reading frame contains 1446
nucleotides, encoding a protein of 481 amino acids
(Fig. 1) and a calculated molecular weight of 54.37 kDa.
The amplified sequence corresponds to the predicted
sequence on Beetlebase (National Center for Biotechnol-
ogy Information (NCBI) reference XM_961484) (Hauser
et al., 2008). Transmembrane (TM) topology prediction
(using PHOBIUS; phobius.sbc.su.se/) revealed the pres-
ence of seven TM segments (TM1–7), the hallmark of all
GPCRs. The large third intracellular loop, characteristic for
biogenic amine receptors, contains four consensus sites
for phosphorylation by protein kinase C (PKC) (S/T-x-R/
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K). The intracellular C-terminal region contains two
cysteines for potential post-translational palmitoylation,
while the extracellular N-terminus contains three consen-
sus sites for glycosylation (N-x-[S/T]). Also other known
5-HT receptors possess several consensus sites for
putative post-translational modifications. Not much is
known about the actual post-translational modifications of
most insect 5-HT receptors, although the 5-HT7 receptor
of A. mellifera was shown to be highly glycosylated
(Schlenstedt et al., 2006).
Trica5-HT7   M----------------------------------------------------------------------------------1
Apime5-HT7   M----------------------------------------------------------------------------------1
Drome5-HT7   MALSGQDWRRHQSHRQHRNHRTQGNHQKLISTATLTLFVLFLSSWIAYAAGKATVPAPLVEGETESATSQDFNSSSAFLG--80
Aedae5-HT7   M--------------------------------DPTVFPLL---------------------------------STLLQQ--15
------------------------------------------------------------------------*
Trica5-HT7   ----------------------------------------------------------------------AANITQDLGI--11
Apime5-HT7   -----------------------------------------------EGKDAITTEDILLLNLT----------TQDVD---23
Drome5-HT7   AIASASSTGSGSGSGSGSGSGSGSGSYGLASMN--------SSPIAIVSYQGITSSNLGDSNTTLVPLSDTPLLLEEFA--151
Aedae5-HT7   SSAQVLPIGDGPTSTVASGVAEVAIINATATINFLEYLLTGNSSSASVSATAIATS-LPALVDRLTPTSSTSSLLDELG---93
*--*---------------------------TM1-------------------------------TM2------------
Trica5-HT7   NETNETSY-QESGYNQAESIIITIILVIIIVGTIVGNILVCVAVCLVRKLRRPSNYLLVSLAVSDLCVALLVMPMAMIYE--90
Apime5-HT7   -GFLQGFPGKNSPYTVTQAILIALVLGSIIVGTVIGNILVCVAVFLVRKLRRPCNYLLVSLAVSDLCVALLVMPMALLYE-102
Drome5-HT7   --------AGEFVLPPLTSIFVSIVLLIVILGTVVGNVLVCIAVCMVRKLRRPCNYLLVSLALSDLCVALLVMPMALLYE-223
Aedae5-HT7   -GTSESSPAEPVNVLTIQTIVISIVLLAVIIGTIVGNVLVCVAVCLVRKLRRPCNYLLVSLAISDLCVAVLVMPPALLYE-172
----------------------TM3----------------------------------------TM4------------
Trica5-HT7   IKGRWIFGEVVCNLWVSFDVLSCTASILNLCMISVDRYYAITKPLEYGVKRTPKRMILWVIVVWCFAACISLPPLLIIGN-170
Apime5-HT7   ISGNWSFGTIMCDLWVSFDVLSCTASILNLCMISVDRFCAITKPLKYGVKRTPRRMIVYVSLVWLGAACISLPPLLIMGN-182
Drome5-HT7   VLEKWNFGPLLCDIWVSFDVLCCTASILNLCAISVDRYLAITKPLEYGVKRTPRRMMLCVGIVWLAAACISLPPLLILGN-303
Aedae5-HT7   VLEEWKFGTVFCDIWVSFDVLSCTASILNLCAISVDRYWAITKPLEYGVKRTPRRMIACIVLVWLVAACISLPPLLILGN-252
--------------------------------TM5--------------------------------------•
Trica5-HT7   EHSEKEENGDINKEVCLVSQDFGYQLYATLCSFYIPLTVMMVVYYKIFRAARKIVMEEKRAQSHLESHCYLEISVKNGGG-250
Apime5-HT7   EHTYSE----TGPSHCVVCQNFFYQIYATLGSFYIPLFVMIQVYYKIFCAARRIVLEERRAQSHLEAHCYFDIEPTVQQH-258
Drome5-HT7   EHEDEE-----GQPICTVCQNFAYQIYATLGSFYIPLSVMLFVYYQIFRAARRIVLEEKRAQTHLQQALNGTGSPSAPQA-378
Aedae5-HT7   EHMTN------GQPSCSVCQNFFYQIYATLCAFYIPLAVMLFVYFQIFRAARRIVNEEKRAQKHLETAIN--GSATTPEK-324
---------------------------------------------------------•-------•------------•
Trica5-HT7   PP----ENKISSQSPSPANPSRINHRSSSASTNTMSSLGRCF--KSRHSNESQCPMLSNKAPIKQTTKDKQQKSSLLASM-324
Apime5-HT7   QPVTVNRQLNSDVQPGHGSPPVKQHRSSSASTTCSGHTVRCFTGGPRKSHESQCPMLQKLE--KPVLSSSTTTTSPMTST-336
Drome5-HT7   PP--------------------LGHTELASSGN-----------GQRHSS------VGNTSLTYSTCGGLSSGGGALAGH-421
Aedae5-HT7   K--------------------------------------------------------------------LSAGG-------330
------------------------------------------------TM6-------------------------TM7-
Trica5-HT7   KSS----------PNTNSTNQKKLRFQLAKERKASTTLGIIMSAFTICWLPFFVLALVRPFLKTTHMLKT-LGSLFLWLG-393
Apime5-HT7   KSTIVRNHLNSTCSVTNSPHQKKLRFHLAKERKASTTLGIIMSAFIVCWLPFFVLALVRPFLKNPDAIPAFLSSLFLWLG-416
Drome5-HT7   GSG---GGVSGSTGLLGSPHHKKLRFQLAKEKKASTTLGIIMSAFTVCWLPFFILALIRPF--ETMHVPASLSSLFLWLG-496
Aedae5-HT7   ------------TVLVATPQHKRLRFQLAKERKASTTLGIIMSAFTVCWLPFFILALVRPFLGEDHHL---LSSLFLWLG-395
-----TM7--------------------- -------------------------
Trica5-HT7   YANSLFNPIIYATLNRDFRKPFQAILYFRCGSLNHMMREEFYHSQYGDPDHHISTRCHLDYEEGVEYIEAEGDEVKTPEI-473
Apime5-HT7   YCNSLLNPIIYATLNRDFRKPFREILYFRCSNLNHMMREEFYQSQYGDPINNCEIKA---GEIDAERLNNQGIESIDIAA-493
Drome5-HT7   YANSLLNPIIYATLNRDFRKPFQEILYFRCSSLNTMMRENYYQDQYGEPP---SQRV-MLGDER-----------------556
Aedae5-HT7   YANSLLNPIIYATLNRDFRKPFQEILFFRCSSLNNMMREDFYHSQYGDPG---SQRLVMAANDG-----------------456
Trica5-HT7   NAAHESFL-481
Apime5-HT7   NAPNESFL-501
Drome5-HT7   HGARESFL-564
Aedae5-HT7   GGARESFL-464
Figure 1. Amino acid sequence alignment of Trica5-HT7 (NCBI Reference XP_966577). Aligment against sequences of orthologous receptors from Apis
mellifera [Apime5-HT7; GenBank CAJ28210, (Schlenstedt et al., 2006)], Drosophila melanogaster [Drome5-HT7; GenBank M55533, (Witz et al., 1990)]
and Aedes aegypti [Aedae5-HT7; GenBank AAG49292, (Pietrantonio et al., 2001)]. Dashes indicate gaps that were introduced to maximize similarities.
Identical residues between orthologous sequences are shown as white characters against black background, and conservative substitutions are shaded.
Putative transmembrane domains are indicated by grey bars above the sequences (TM1-7). Asterisks (*) indicate putative N-linked glycosylation sites in
the N-terminal region, dots (●) indicate putative phosphorylation sites for PKC, and diamonds (◆) indicate possible palmitoylation sites. Amino acid
position numbers are indicated at the right. Alignment was performed using the multiple sequence alignment program MAFFT (version 7) (Katoh et al.,
2002, 2005).
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General Family-A GPCR characteristics are present in
the amino acid sequence, such as the D3.49R3.50Y3.51
sequence at the start of the second intracellular loop
(numbering according to the Ballesteros-Weinstein
system (Ballesteros & Weinstein, 1995)). This highly con-
served tripeptide sequence is believed to have a key role
in receptor activation (Bockaert & Pin, 1999; Gether,
2000). Several other properties of aminergic receptors are
present, such as the consensus sequence F6.44-x-x-x-
W6.48-x-P6.50 in TM6 followed by a pair of phenylalanine
residues, and the combination of a conserved aspartic
acid in TM3 (D3.32) and tryptophan in TM7 (W7.40). The
negatively charged side chain of D3.32 is thought to interact
with the protonated amine moiety of amine ligands. The
conserved N7.49P7.50-x-x-Y7.53 motif in TM7 is present as
well. Mutagenesis experiments along this motif have been
shown to affect the receptor’s ligand affinity, G protein
coupling, receptor signalling, desensitization and internali-
zation (Barak et al., 1994; Gales et al., 2000; Gripentrog
et al., 2000; Bouley et al., 2003; Fritze et al., 2003;
Kalatskaya et al., 2004; Johnson et al., 2006; Borroto-
Escuela et al., 2011). As other insect 5-HT7 receptors,
Trica5-HT7 contains the sequence ESFL at its C-terminus.
This corresponds to the consensus motif of class I PDZ-
binding domains (E-[S/T]-x-Φ; with Φ being a hydrophobic
amino acid, mostly V, L or I). PDZ domains are protein–
protein interaction domains that play a role in protein
targeting and protein complex assembly; however, no
interactions with scaffolding proteins have as yet been
reported for insect 5-HT receptors.
Comparison of the Trica5-HT7 amino acid sequence
with other 5-HT receptor orthologues revealed high
sequence similarities to cognate insect 5-HT7 receptors.
The overall amino acid similarity (identical and conserva-
tively substituted amino acids) compared with 5-HT7
sequences of other insects was 74.4% for A. mellifera
(Schlenstedt et al., 2006), 70.0% for D. melanogaster
(Witz et al., 1990) and 66.3% for Ae. aegypti (Pietrantonio
et al., 2001). The similarity within the TM regions is even
higher (A. mellifera, 93.3% similarity; D. melanogaster,
94.5% similarity; and Ae. aegypti, 95.1% similarity). The
overall amino acid sequence similarity to human 5-HT7
splice variants ranges from 52.8% to 54.9%. Within the
TM regions, similarity of Trica5-HT7 was 68.6% with all
human isoforms. These percentages are similar to the
ones observed when other characterized insect amine
receptors are compared with their orthologues in other
species or taxa.
A multiple sequence alignment of different invertebrate
and human 5-HT receptor sequences was used to con-
struct a phylogenetic tree (Fig. 2). This phylogenetic
analysis allows the evolutionary grouping of the three
known invertebrate 5-HT receptor types. Trica5-HT7 clus-
ters with other known insect and human 5-HT7 receptors.
Highest similarity of the receptor was shown with the
5-HT7 receptor of A. mellifera. Based on this available
sequence information, insects seem to possess one
5-HT7-type serotonin receptor, but may have two 5-HT1
(e.g. D. melanogaster and T. castaneum) and/or two
5-HT2 receptors (e.g. D. melanogaster and A. mellifera).
This again shows that additional information on receptor
pharmacology and downstream signalling may be of great
importance to more accurately describe and classify inver-
tebrate 5-HT receptors.
Receptor transcript distribution
Quantitative reverse transcription (RT)-PCR was used to
compose a general tissue distribution profile. Expression
levels were higher in the head than in the gut, the fat
body and the reproductive system (Fig. 3A). More detailed
study of the head indicated the highest expression in the
brain (without optic lobes), and about half of this transcript
level was observed in the optic lobes (Fig. 3B). This dis-
tribution is not surprising since serotonin is considered
an important neurotransmitter. In C. vicina, 5-HT7 receptor
RT-PCR also showed highest expression in the brain
(Roser et al., 2012). In A. mellifera, in situ hybridization
showed expression of the Apime5-HT7 receptor in all
major regions of forager brains (Schlenstedt et al., 2006).
Expression in different regions of the brain, such as the
optic lobes, the antennal lobes and the mushroom bodies
might indicate a role in neural pathways involved in pro-
cessing sensory information and learning. Also other 5-HT
receptors are shown to be expressed in insect brains
(Schlenstedt et al., 2006; Thamm et al., 2010; Troppmann
et al., 2010; Blenau & Thamm, 2011; Roser et al., 2012;
Vleugels et al., 2013). Expression of Trica5-HT7 in the
salivary glands was relatively low compared with brain
tissue, and was about the same as in the gut. Transcript
levels in the gut might be due to expression in nervous
tissue associated with the digestive tract. In Ae. aegypti,
the 5-HT7 receptor has been localized in axons that run in
parallel with the hindgut. Since anti-5-HT antibodies
showed no reactivity in the hindgut, 5-HT is probably
not released locally, but rather acts as a hormone on
the hindgut (Pietrantonio et al., 2001). In Ae. aegypti,
A. mellifera and C. vicina, expression was also observed
in the Malpighian tubules.
Functional information on the role of insect 5-HT recep-
tors is still very limited. In Ae. aegypti, expression of 5-HT7
in the tracheolar cells associated with the Malpighian
tubules indicates a possible role for this receptor in respi-
ration. Apime5-HT1 has been suggested to mediate
reduced positive phototactic behaviour in the honeybee
(Thamm et al., 2010), while the negative effect on food
intake of the 5-HT receptor antagonist methiothepin in
Drosophila larvae was shown to be mediated by the
4 R. Vleugels et al.
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5-HT2A receptor (Gasque et al., 2013). More functional
studies, however, must be performed to assign clear func-
tions to these receptors.
Cell-based analysis of receptor pharmacology
Agonists. To examine receptor pharmacology, we
employed a cell line stably expressing the promiscuous
Gα16 protein to measure agonist-mediated receptor activa-
tion. Neither non-transfected cells, nor cells transfected
with empty pcDNA3.1D vector responded to 5-HT (results
not shown). After transfection with different quantities of
Trica5-HT7/pcDNA3.1D vector, no signal could be meas-
ured in non-agonist stimulated cells. The effects of 5-HT
and the possible 5-HT receptor agonists αm-5-HT, 5-CT,
5-MT and 8-OH-DPAT were measured in cells transfected
with Trica5-HT7/pcDNA3.1D vector. High doses (100 μM)
of the synthetic agonists activated the receptor, but only
half as much as 5-HT (Fig. 4A). The dose–response
relationship was examined for 5-HT with concentrations
ranging from 1 pM to 1 mM. The resulting sigmoidal
dose–response curve shows receptor activation in
a dose-dependent and saturable manner (Fig. 4B).
Maximum activation was achieved with 5-HT con-
centrations ≥5 μM. Half-maximum activation (EC50) was
obtained at 5-HT concentrations of 27.3 nM (logEC50 =
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Figure 2. Maximum-likelihood tree of various invertebrate and human 5-HT receptors. Alignment was performed with amino acid sequences from TM1-5
and TM6-7. GenBank accession numbers are indicated in the tree, followed by the receptor name between brackets. The FMRFamide receptor of
Drosophila melanogaster (isoform A) was used as outgroup. Phylogenetic and molecular evolutionary analyses were conducted by MEGA version 5.10
(Jones–Taylor–Thornton substitution model). Bootstrap values are based on 5000 replicates and are indicated on the nodes. The scale bar allows
conversion of branch lengths in the dendogram to genetic distances between clades (0.2–20% genetic distance). Abbreviations used: Papxu, Papilio
xuthus; Helvi, Heliothis virescens; Manse, Manduca sexta; Drome, Drosophila melanogaster; Trica, Tribolium castaneum; Peram, Periplaneta americana;
Panin, Panulirus interruptus; Procl, Procambarus clarkii; Apime, Apis mellifera; Bommi, Bombyx mori; Lymst, Lymnea stagnalis; Aedae, Aedes aegypti;
Calvi, Calliphora vicina.
Pharmacological characterisation of Trica5-HT7 5
© 2013 Royal Entomological Society
−7.56 ± 0.04, mean ± SEM). For other insect 5-HT7 recep-
tors, EC50 values were in the nanomolar range as well
(1.06–1.75 nM in A. mellifera; 4 nM in C. vicina; 39.5 nM
in Ae. aegypti) (Lee & Pietrantonio, 2003; Schlenstedt
et al., 2006; Roser et al., 2012). Also the characterized
5-HT1-type receptor of T. castaneum (Trica5-HT1) had a
comparable EC50 value (Vleugels et al., 2013). The
biogenic amines dopamine, octopamine and tyramine did
not induce detectable responses at concentrations up to
100 μM (results not shown), confirming that we character-
ized a specific serotonin (5-HT) receptor.
The dose–response relationship for potential agonists
was measured the same way with concentrations from
100 pM to 1 mM. Since the efficacy achieved by any
agonist depends on the number of receptors expressed,
we measured a dose–response curve for 5-HT in every
experiment and normalized all agonist effects to the
maximum 5-HT response (Fig. 4B). The EC50 values of the
synthetic agonists in the micromolar range indicate that
they are considerably less potent than 5-HT (Table 1).
The mammalian 5-HT2 receptor agonist αm-5-HT is most
potent with an EC50 value of 5.19 μM (logEC50 =
−5.29 ± 0.21), although still almost 200-fold less potent
than 5-HT. Responses produced by the highest concen-
tration of the synthetic agonists were also consistently
weaker than the 5-HT-evoked responses (Fig. 4). High
concentrations (1 mM) of 8-OH-DPAT, a partial and selec-
tive agonist for mammalian 5-HT1 and 5-HT7 receptors,
resulted in 60% activation compared with a maximum
level of stimulation obtained with 5-HT. The efficacies of
the other agonists were below 50% of the maximum
response of 5-HT. Especially the non-selective mamma-
lian 5-HT receptor agonist, 5-MT, and the selective agonist
for mammalian 5-HT1 and 5-HT7 receptors, 5-CT, showed
Figure 3. Expression profiles of transcripts encoding Trica5-HT7 in sexually mature beetles. The data represent mean values of (A) three independent
samples of 30 x heads, 50 x guts, 20 x fat body and 50 x reproductive system; and (B) three independent samples of 15 beetles each; run in
duplicate ± SEM, normalized relative to RPS3 (ribosomal protein subunit 3), RPS18 and actin transcript levels. Statistically significant differences are
indicated by asterisks above the bars (P ≤ 0.05) (Kruskal–Wallis, IBM SPSS Statistics 20). Abbreviations: FB, fat body; RS, reproductive system; Brain,
brain without the optic lobes; OL, optic lobes; SalGl, salivary glands.
Figure 4. Effect of various possible 5-HT receptor agonists on Trica5-HT7 in CHO-WTA11 cells. (A) Receptor activation in CHO-WTA11 cells after
stimulation with 100 μM of agonist, shown as the percentage of activation achieved with 100 μM of 5-HT (indicated as 100%). (B) Dose–response curves
with receptor activation shown as the percentage of activation achieved with 1 mM 5-HT (indicated as 100%). Data represent the mean ± SEM of 11
independent measurements in duplicate for 5-HT; six independent measurements (three in duplicate, three in triplicate) for 5-MT and 5-CT; seven
independent measurements (four in duplicate, three in triplicate) for αm-5-HT and 8-OH-DPAT.
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only poor responses compared with 5-HT. Low efficacies
and partial agonism were also observed in other insects.
For example, in A. mellifera, 5-CT was shown to be a
potent agonist of Apime5-HT7 (EC50 = 24.3–40.0 nM),
although its efficacy was about four times lower than 5-HT
(Schlenstedt et al., 2006). For Trica5-HT1, the synthetic
agonists also showed lower potencies and efficacies
than 5-HT. On Trica5-HT1, the agonist αm-5-HT was both
the most potent (with an EC50 value ∼10.7 μM) and most
efficient (∼80% of the 5-HT response) (Vleugels et al.,
2013).
Mammalian 5-HT7 receptors have the unique pharma-
cological profile with a rank order of potency 5-CT > 5-
HT > 8-OH-DPAT (Gerhardt & van Heerikhuizen, 1997);
however, none of the synthetic agonists seems to be as
potent as 5-HT on Trica5-HT7, nor on other insect 5-HT7
receptors (Witz et al., 1990; Lee & Pietrantonio, 2003;
Schlenstedt et al., 2006; Roser et al., 2012). On Apime5-
HT7, the agonist 5-CT was only little less potent than 5-HT,
while 8-OH-DPAT was only a poor agonist (Schlenstedt
et al., 2006). In C. vicina, 5-HT was a much stronger
agonist of the Calvi5-HT7 receptor than its analogue 5-CT,
which in its turn was much more active than 8-OH-DPAT
(Roser et al., 2012). For most insect 5-HT7 receptors, the
rank order of potencies for these agonists thus appears to
be: 5-HT > 5-CT > 8-OH-DPAT; however, the 5-HT7 recep-
tors of Ae. aegypti showed only weak activity upon stimu-
lation with 5-CT or 8-OH-DPAT (Lee & Pietrantonio, 2003).
It also has to be mentioned that the ergot derivate R(+)-
lisuride was as potent as 5-HT in activating Calvi5-HT7
(Roser et al., 2012); however, its activity will probably not
be restricted to 5-HT7 receptors, since it is also known as
an agonist of mammalian dopamine D2 receptors and
several other types of 5-HT receptors.
Antagonists. Potential inhibition by synthetic antagonists
was measured by simultaneously applying nanomolar
concentrations of 5-HT (around the EC50 value) and a
high dose of antagonist (100 μM). All tested antagonists
decreased the 5-HT response (Fig. 5A) and dose-
dependent relationships were investigated with antago-
nist concentrations ranging from 100 nM to 1 mM.
Ketanserin, a selective antagonist of mammalian 5-HT2
receptors, and methiothepin, a non-selective antagonist
of mammalian 5-HT and dopamine receptors were most
potent in inhibiting the agonist induced response on
Trica5-HT7 elicited at a 5-HT concentration of 10−7.5 M
(= 31.6 nM; ∼ EC50 value) (Fig. 5B). Their half-maximum
Table 1. EC50 values of agonists for Trica5-HT7 receptor activation in
CHO-WTA11 cells
Agonist EC50, μM log(EC50, mean ± SEM
5-HT 0.0273 −7.56 ± 0.042
αm-5-HT 5.19 −5.29 ± 0.21
5-CT 22.28 −4.65 ± 0.28
5-MT 30.28 −4.52 ± 0.28
8-OH-DPAT 38.75 −4.41 ± 0.15
Figure 5. Effect of various possible 5-HT receptor antagonists on Trica5-HT7 stimulated with 5-HT (10−7.5 M) in CHO-WTA11 cells. (A) Effect of
100 μM antagonist shown as the percentage of activation achieved with 10−7.5 M (= 31.6 nM; ∼ EC50 value) of 5-HT (indicated as 100%). (B and C)
Dose–response curves with receptor activation shown as the percentage of activation achieved with 10−7.5 M 5-HT (indicated as 100%). Cells treated with
BSA-medium only were used to define the basal level of 0%. Data represent the mean ± SEM of three (butaclamol and metysergide) or four (ketanserin)
measurements in triplicate; or three measurements in triplicate and two (methiothepin and yohimbine) or three (prazosin, SB-269970 and WAY-100635)
measurements in duplicate, or two (mianserin) measurements (one in duplicate, one in triplicate).
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inhibitory concentration (IC50) values were 1.95 μM
(logIC50 = −5.71 ± 0,25) and 6.98 μM (logIC50 = −5.16 ±
0,27), respectively. The IC50 values for all tested antago-
nists are indicated in Table 2. Ketanserin is known to be a
moderate antagonist of Calvi5-HT7, but was also shown
to moderately inhibit activation of 5-HT2 receptors in
D. melanogaster (Colas et al., 1995) and C. vicina (Roser
et al., 2012). Also in Caenorhabditis elegans, ketanserin
was a rather potent inhibitor of the 5-HT7 receptor SER-7
(Hobson et al., 2003). Ketanserin did not show any
detectable effects on Trica5-HT1 (Vleugels et al., 2013),
but before using it as a selective blocker for Trica5-HT7,
it has to be confirmed that it does not act on other recep-
tors in T. castaneum. Methiothepin on the other hand,
was shown to be a potent inverse agonist of the consti-
tutively active Apime5-HT7 (Schlenstedt et al., 2006),
although the effect could not be calculated for Calvi5-HT7.
Membrane replacement studies also designate high pKi
values for SER-7 of C. elegans (Hobson et al., 2003).
Methiothepin was also one of the most potent antagonists
of Trica5-HT1 (Vleugels et al., 2013) and has been shown
to moderately inhibit several other type 1 and type 2 5-HT
receptors of insects and other invertebrates (Sugamori
et al., 1993; Colas et al., 1995; Olde & McCombie, 1997;
Angers et al., 1998; Hamdan et al., 1999; Barbas et al.,
2002; Troppmann et al., 2010; Roser et al., 2012). In
D. melanogaster, methiothepin was even shown to
antagonize all known 5-HT receptors (Gasque et al.,
2013), indicating that methiothepin indeed has a rather
broad antagonistic activity.
The phenylpiperazine drug, WAY-100635, known to
inhibit mammalian 5-HT1A receptors, and the plant
alkaloid, yohimbine, known to block mammalian α2-
adrenergic receptors as well as locust tyramine
receptors (Vanden Broeck et al., 1995), exhibit clear
dose-dependent inhibition on 5-HT induced Trica5-HT7
(Fig. 5B). WAY-100635 has been shown to be an inverse
agonist of the 5-HT1 receptor of Periplaneta americana
(Troppmann et al., 2010). Yohimbine had only a moderate
inhibitory effect on Calvi5-HT7, but a higher antagonistic
activity was measured for Calvi5-HT2α. Both WAY-100635
and yohimbine thus do not seem very specific for a given
insect receptor type. The dose–response curves of
butaclamol (a mammalian dopamine receptor antagonist),
methysergide (a 5-HT2 receptor antagonist and partial
5-HT1 agonist) and prazosin (a selective mammalian
α1-adrenergic receptor antagonist) do not drop below
40% inhibition indicating rather low antagonistic efficiency
(Fig. 5C). For butaclamol, a 1 μM concentration was not
tested, since this could not be dissolved properly in the
medium. Prazosin and methysergide were shown to be
efficient and potent antagonists of Trica5-HT1 (Vleugels
et al., 2013). Mianserin, a selective antagonist of mamma-
lian 5-HT2 receptors, shows no clear dose-dependent inhi-
bition on Trica5-HT7. Also for SB-269970 no pronounced
dose-dependency could be observed, although known as
a selective antagonist of mammalian 5-HT7 receptors
(Lovell et al., 2000); however, more recently SB-269970
was also shown to block α2-adrenergic receptors (Foong
& Bornstein, 2009). SB-269970 has been shown to be a
very potent antagonist of Calvi5-HT7, but only showed a
weak inhibitory efficacy of about 15%. The highest inhibi-
tory efficacy was 77% of the 5-HT response (in the pres-
ence of 6 nM 5-HT), and was achieved with clozapine.
This is a monoaminergic antagonist with high affinity for
several mammalian biogenic amine receptors including
5-HT2 receptors; however, clozapine did not block
Apime5-HT7, on which SB-269970 also induced only poor
antagonistic effects.
The two most potent antagonists that showed a dose-
dependent response were investigated in more detail
by looking at the dose–response relationship of 5-HT in
the presence of different concentrations of antagonist
(100 nM to 1 mM). Higher concentrations of antagonists
resulted in a rightward shift of the 5-HT dose–response
curves (Fig. 6) and consequently higher EC50 values for
5-HT activity. The efficacy of 5-HT did not change in pres-
ence of the antagonists. The Gaddum/Schild plot was
used to examine the nature of inhibition and to calculate a
pA2 value (i.e. a negative logarithm of the concentration of
antagonist that doubles the amount of 5-HT required for
obtaining the same effect). The slope of the Schild plot
for methiothepin was 0.93 (0.84–1.01; 95% CI) and
methiothepin can thus be considered a true competitive
antagonist of Trica5-HT7. The pA2 value of methiothepin
was 6.50 (± 0.16). The Schild slope for ketanserin was
much lower than 1, which indicates that the rightward shift
of the dose–reponse curves was less than predicted by
competitive inhibition; however, the main characteristics of
competitive inhibition are present: a rightward shift of the
dose–response curves of 5-HT with increasing concentra-
tion of antagonist, and the plateau for maximum 5-HT
response was maintained, even at high antagonist con-
centrations. Taken together, ketanserin and methiothepin
seem to be potent antagonists of Trica5-HT7. Although
Table 2. IC50 values of antagonists for Trica5-HT7 receptor activation in
CHO-WTA11 cells (at 10−7.5 M 5-HT concentration)
Antagonist IC50, μM log(IC50, mean ± SEM
Ketanserin 1.95 −5.71 ± 0,25
Methysergide 6.98 −5.16 ± 0,27
Methiothepin 7.91 −5.10 ± 0,14
Butaclamol 13.65 −4.87 ± 0,44
Prazosin 14.82 −4.83 ± 0,30
SB-269970 15.82 −4.80 ± 0,21
Yohimbine 32.55 −4.49 ± 0,13
WAY-100635 76.80 −4.12 ± 0,18
Mianserin Irrelevant to calculate
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methiothepin is not selective, since it also interacts with
Trica5-HT1 in the same concentration range as with
Trica5-HT7 (Vleugels et al., 2013). The selectivity of
ketanserin needs to be verified in studies with other 5-HT
(and biogenic amine) receptors of T. castaneum (and
other insects), especially 5-HT2. In C. vicina, ketanserin
indeed showed some inhibitory activity on Calvi5-HT2.
The differences in pharmacological profiles between
mammalian and insect receptors are probably attributable
to the large evolutionary distance between protostomes
and deuterostomes. Although the main receptor types
were probably present in their common ancestor, a con-
siderable divergence has occurred independently in
receptors of mammals and insects. This may explain the
existence of different receptor subtypes with specific phar-
macological properties (Tierney, 2001). Selection during
this evolution was probably based on functionally impor-
tant receptor characteristics, such as ligand binding and G
protein coupling, and this did not necessarily lead to con-
servation of recognition sites for man-made, synthetic
ligands. Also, between different insects, differences in
potency and efficacy can be observed for the agonists and
antagonists that were originally designed for and applied
to vertebrate (mainly mammalian and human) receptor
types. Their specificity towards invertebrate (insect)
receptors has never been profoundly tested or compared.
It will therefore be of great interest to screen for synthetic
compounds that more specifically target the insect recep-
tor types.
Downstream signalling
CHO-PAM28 cells were used to determine whether
Trica5-HT7 couples to the Ca2+ signalling pathway. No
effect of 5-HT was observed in these cells transfected with
empty vector or Trica5-HT7 containing vector. So we can
conclude that the receptor does not couple via Gq to the
calcium-signalling pathway. In HEK293 cells, effects on
the intracellular cAMP levels were examined by means of
a CRE-based bioluminescent reporter assay. Basal levels
of cAMP did not significantly change in cells transfected
with an empty vector. Also no indications for a constitutive
activity of the receptor were observed when comparing
basal cAMP-dependent reporter levels (i.e. in the absence
of 5-HT) in Trica5-HT7-expressing cells and in cells
transfected with empty vector. There was also no inhibi-
tory effect on NKH-477 (a forskolin analogue)-stimulated
cyclic AMP levels; however, in cells expressing Trica5-
HT7, a dose-dependent increase in intracellular cAMP
levels was measured upon stimulation with 5-HT (10 pM
to 100 μM) (Fig. 7). Maximum response was obtained
with 5-HT concentrations ≥10 μM. Half-maximum re-
sponse levels were observed at 6.56 nM 5-HT (logEC50 =
−8.18 ± 0.20, mean ± SEM). Trica5-HT7 thus stimulates the
cAMP production, probably via the Gs protein. This is in
Figure 6. Dose-dependent activation of Trica5-HT7 with 5-HT (0.1 nM–100 μM) in CHO-WTA11 cells, in the presence of different concentrations of
antagonist (100 nM–1 mM). (A) methiothepin and (B) ketanserin. Receptor activity is shown as the percentage of activation achieved with 100 μM of
5-HT in the absence of antagonist (set at 100%). Cells treated with BSA-medium only were used to define the basal level of 0%. Data represent the
mean ± SEM of two independent measurements (each performed in duplicate). NA, no antagonist.
Figure 7. Dose-dependent effect of 5-HT (1 pM–100 μM) on the
luciferase bioluminescence in HEK293 cells expressing Trica5-HT7 as a
result of changes in intracellular cAMP levels. Receptor activity is shown
as the percentage of activation achieved with 100 μM of NKH-477 (set
at 100%). Luciferase bioluminescence due to basal intracellular cAMP
levels is set at 0%. The data represent the mean ± SEM of four
independent measurements (one performed in duplicate, two in
triplicate, and one in quadruplicate).
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line with functional data for other 5-HT7 receptors. The fact
that both the amino acid sequence and the second mes-
senger system are similar for 5-HT7 receptors of both
insects and vertebrates, is probably because 5-HT recep-
tor types emerged from early gene duplications (followed
by mutations and sequence drift) (Vernier et al., 1995).
The small difference in EC50 values for 5-HT measured in
CHO and HEK cells, 27.3 and 6.6 nM respectively, might
be explained by differences between both cell lines in the
number of receptors exposed at the plasma membrane, in
the levels of interacting proteins (including different G
proteins), in the effector systems generating second mes-
sengers and/or in cellular metabolism. For example, the
relative concentration of G proteins present in a given cell
line might influence agonist-induced second messenger
production (Bockaert et al., 1997). The different read out
required for the different signals might also contribute
to differences in EC50 value. It should be noted here as
well that possible imparities may exist between effects
observed in cultured cell lines and physiological signalling
processes occurring within the in vivo context of an organ-
ism (Bockaert et al., 1997; Kenakin, 1997).
Conclusions
Sequence information as well as second messenger cou-
pling of the Trica5-HT7 receptor resemble those of its
vertebrate orthologues. The amino acid sequence of this
receptor shows the characteristic features of biogenic
amine GPCRs, as well as high similarity to other (insect)
5-HT7 type serotonin receptors. As all known 5-HT7 recep-
tors, Trica5-HT7 was dose-dependently activated by 5-HT,
which induced elevated intracellular cAMP levels. These
findings support other studies indicating that the main
5-HT receptor types result from early gene duplications in
the common ancestor of insects and mammals.
By contrast, the known agonists and antagonists of
mammalian 5-HT receptors do not seem to have the same
selectivity on insect 5-HT receptors. The synthetic
agonists, αm-5-HT, 5-CT, 5-MT and 8-OH-DPAT, were
much less potent and efficient than 5-HT in activating
Trica5-HT7. From nine tested antagonists, ketanserin and
methiothepin appeared to be most potent. In vertebrates,
ketanserin is known as a selective antagonist of 5-HT2
receptors, and methiothepin as a non-selective antagonist
of both 5-HT and dopamine receptors.
The relatively low potencies of these synthetic ligands,
as compared with 5-HT, and their differences in affinity for
insect and mammalian receptors indicate the importance
of profound pharmacological analyses of 5-HT receptor
types in insects. Detailed study of insect 5-HT receptors
is necessary to identify type-specific pharmacological
ligands and to make an insect (or invertebrate) specific
classification. For this, it may be necessary to screen for
new compounds that efficiently target the insect receptor
types. Specific stimulatory and inhibitory pharmacological
agents will offer very helpful tools for functional studies
and/or practical applications (e.g. research, medical use,
pest management).
Experimental procedures
Drugs
The pharmacological ligands 3-hydroxytyramine (dopamine)
hydrochloride, 5-carboxamidotryptamine maleate (5-CT), 5-HT
hydrochloride (5-HT), 5-methoxytryptamine (5-MT), (±)-8-
hydroxy-2-(dipropylamino)tetralin hydrobromide (8-OH-DPAT),
α-methylserotonin maleate (αm-5-HT), (+)-butaclamol hy-
drochloride, ketanserin (+)-tartrate, methiothepin mesylate,
methysergide maleate, mianserin hydrochloride, prazosin
hydrochloride, DL-octopamine hydrochloride, SB-269970 hydro-
chloride (SB-269970 = (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2 -(2-
(4-methyl-1-piperidinyl)ethyl)pyrrolidine), tyramine hydrochloride,
WAY-100635 maleate (WAY-100635 = N-(2-[4-(2-methoxyph-
enyl)-1-piperazinyl]-ethyl)-N-(2-pyridinyl) cyclohexanecarboxa-
mide), and yohimbine hydrochloride were purchased from
Sigma-Aldrich (St Louis, MO, USA).
Cloning of Trica5-HT7 receptor cDNA
Oligonucleotide primers (sense primer 5′-CACCATGGCGGCC
AATATAACTCAAGA-3′ and antisense primer 5′-TCATAGAAAC
GATTCGTGTGCTGC-3′) were designed based on sequences
available in Beetlebase released by the Human Genome
Sequencing Center (Tcas_3.0; http://www.beetlebase.org/)
(Hauser et al., 2008; Kim et al., 2010). The sequence, CACC, at
the 5′ end of the sense primer is essential to enable directional
cloning. The sequence encoding a Trica5-HT7 receptor was
amplified by means of PCR on whole body cDNA from adult
T. castaneum beetles using Pwo DNA polymerase (Roche
Applied Science, Indianapolis, IN, USA) and according to the
protocol of the kit. The following PCR cycling programme was
used: 94 °C for 2 min, followed by 30 cycles of [94 °C for 15 s,
65 °C for 30 s, 72 °C for 2 min], followed by a final elongation on
72 °C for 7 min. The PCR product was run on a 1% agarose gel,
from which it was purified using the GenElute™ Gel Extraction Kit
(Sigma-Aldrich). The purified DNA fragments were ligated into
the directional pcDNA3.1D/V5-His-TOPO® expression vector
(Invitrogen, Carlsbad, CA, USA). The vectors were then trans-
formed in One Shot TOP10 chemically competent Escherichia
coli cells (Invitrogen), which were grown overnight on 37 °C on
lysogeny broth (LB) agar plates (35 g/l) with ampicillin (final con-
centration 50 μg/ml). Colonies were transferred to LB medium
(25 g/l) with ampicillin (final concentration 50 μg/ml) and grown
overnight on 37 °C in a horizontal shaker. Plasmids were isolated
using the GenElute™ HP Plasmid Miniprep kit (Sigma Aldrich)
and the inserted DNA sequences were verified on an ABI PRISM
3130 Genetic Analyzer (Applied Biosystems, Foster City, CA,
USA) following the protocol outlined in the ABI PRISM BigDye
Terminator Ready Reaction Cycle Sequencing Kit (Applied
Biosystems). Bacterial cells known to contain the correct receptor
insert were grown at large scale in 100 ml LB broth medium
(25 g/l) with ampicillin (final concentration 50 μg/ml). The expres-
sion vectors were subsequently isolated from these cells using
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the EndoFree Plasmid Maxi Kit (Qiagen, Hilden, Germany)
according to the protocol recommended by the manufacturer.
Multiple sequence alignment and phylogenetic analysis
Amino acid sequences used for the sequence alignment were
identified in the protein database of the NCBI with the amino acid
sequence of Trica5-HT7 as template. The multiple sequence
alignment was performed with MAFFT (L-INS-i method) (Katoh
et al., 2002, 2005). The alignment for the phylogenetic tree is
based on the conserved regions TM1–5 and TM6–7, and was
performed using MEGA software (version 5.10) (Tamura et al.,
2011) using Muscle [MUltiple Sequence Comparison by Log-
Expectation; (Edgar, 2004a, b)]. In MEGA, the genetic distance
between sequences was calculated and a maximum likelihood
tree was constructed using Jones–Taylor–Thornton amino acid
substitution model. The reliability of the tree was estimated by
5000-fold bootstrap re-sampling.
Quantitative real-time PCR
For determination of expression levels of the receptor, tissues
from sexually mature T. castaneum were dissected in phosphate
buffered saline (PBS; NaCl 137 mM, KCl 2.7 mM, Na2HPO4
10 mM, KH2PO4 1.76 mM; pH 7.2), pooled and snap-frozen in
liquid nitrogen. Tissues were subsequently homogenized and
total RNA was extracted using the RNAqueous Micro Kit (Ambion,
Austin, TX, USA) according to the protocol recommended by the
kit, which included an additional DNase I digestion to degrade
remaining contaminating genomic DNA. Total RNA was reverse
transcribed into cDNA using SuperScriptIII reverse transcriptase
(Invitrogen) as recommended by the manufacturer, and cDNA
was diluted ten-fold before use. Transcript levels were quantified
using the Fast Sybr Green assay kit (Applied Biosystems) in a
StepOne Plus detection system (ABI Prism, Applied Biosystems).
Primers were used in final concentrations of 500 nM: sense
primer 5′-TGAAATCCTCGCCGAACAC-3′ and antisense primer
5′-TCGCTAGTTGAAAGCGAAGCT-3′ (Sigma-Aldrich). Other
conditions were as recommended by the manufacturer. Reac-
tions were run in duplicate and incubated on 50 °C for 2 min,
followed by 95 °C for 10 min, followed by 40 cycles of [95 °C for
15 s and 60 °C for 1 min]. The specificity of the PCR products
was assessed generating a dissociation curve (95 °C for 15 s,
60 °C for 1 min, and increase in temperature in 0.7 °C increments
from 60 °C to 95 °C). Agarose gel electrophoresis of the PCR
products confirmed the presence of a single band of the expected
size and sequencing confirmed their identity. The relative quantity
of target cDNA was quantified using the ΔΔCT-method including
normalization to a calibrator on all PCR plates and an endog-
enous control. From a list of nine housekeeping genes (Sup-
plementary table), ribosomal proteins RPS3 and RPS18 (with the
ratio RP18/RP13 equal to 0.8), and actin were selected using
geNorm (Vandesompele et al., 2002) as stable genes with
respect to sex and tissue (Vuerinckx et al., 2011). These three
genes were used as endogenous control to normalize all
samples.
Cell culture and transfections
General binding studies were performed in Chinese hamster
ovary (CHO-)WTA11 cells stably coexpressing apoaequorin and
the promiscuous Gα16 to determine the pharmacology indepen-
dently of the downstream signalling. CHO-PAM28 cells stably
expressing apoaequorin, but not the promiscuous Gα16, and
human embryonic kidney (HEK-)293 cells were employed to
measure the functional signalling activity of the receptor via Ca2+
and cAMP, respectively.
All cells were cultured as monolayers in Dulbecco’s
Modified Eagle Medium Nutrient Mixture F12-Ham (DMEM/F12,
Invitrogen) supplemented with 1% penicillin/streptomycin (10 000
units/ml penicillin and 10 mg/ml streptomycin in 0.9% NaCl)
(Invitrogen) to prevent bacterial contamination of gram-positive
and gram-negative bacteria, respectively. For CHO-WTA11 cells,
250 μg/ml zeocin (Invitrogen) was added and for CHO-PAM28
cells, 5 μg/ml puromycin dihydrochloride (Invitrogen) was added.
The medium for CHO cells was supplemented with 10% fetal calf
serum (inactivated at 65 °C, Sigma-Aldrich) and the medium for
HEK293 cells was supplemented with 2% Ultroser G serum sub-
stitute (Pall Life Sciences). The cells were cultured in T25 flasks
at 37 °C, in high relative humidity, with constant supply of 5% CO2
and were subcultivated every 3 days at confluencies of 80–90%.
Transfections with either Trica5-HT7/pcDNA3.1D or empty
pcDNA3.1D vector were performed at ca. 60% confluency. For
CHO cells, transfection reagent was prepared combining 2.5 ml
Opti-MEM®I (Invitrogen), 5 μg plasmid DNA and 12.5 μl
PlusTMreagent (Invitrogen), stored at room temperature for 5 min
and next repleted with 30 μl Lipofectamine™LTX (Invitrogen).
After 30 min incubation at room temperature, the transfection
mixture was added dropwise to the cells together with 5 ml
medium. HEK293 cells were similarly cotransfected with 4 μg
receptor construct and 2 μg CRE-luciferase construct (consisting
of the open reading frame of the luciferase gene, downstream of
a multimerized cAMP response element). Subsequently, the cells
were grown overnight, next supplemented with 15 ml of medium
for an additional overnight incubation period.
Bioluminescent assays
Transfected CHO cells were detached 2 days after transfection
with PBS containing 0.2% EDTA and collected in DMEM/F-12
(without phenol red, with L-glutamine and 10 mM HEPES)
(Gibco, Paisley, UK) to determine the amount of viable cells
using a NucleoCounter® NC-100+TM (Chemometec, Alloroed,
Denmark). Cells were next pelleted at 1240 g for 4 min at room
temperature and resuspended in BSA-medium (DMEM/F12
without phenol red, with L-glutamine and 10 mM HEPES, sup-
plemented with 1% bovine serum albumin) to a concentration of
5 × 106 cells/ml. Coelenterazine H (Invitrogen) was added to a
final concentration of 5 μM, allowing the aequorin holoenzyme to
be reconstituted. Cells were gently shaken for 4 h at room tem-
perature in the dark. After a 10-fold dilution in BSA-medium, cells
were incubated another 30 min. After incubation, receptor activity
was measured as the light emission after injecting 50 μl of the cell
suspension in wells with an equal volume of BSA-medium
containing the dissolved pharmacological ligand (50 μl agonist
solution, or 25 μl antagonist supplemented with 25 μl 5-HT
solution). Since the efficacy depends on the number of receptors
expressed, we measured a dose–response curve for 5-HT in
every experiment and normalized all effects to this 5-HT
response. Light emission was monitored during 30 s using a
Mithras LB940 Microplate Reader (Berthold Technologies, Bad
Wildbad, Germany). Cells were subsequently lysed with Triton
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X-100 (2 μl per ml BSA-medium), serving as an internal refer-
ence. BSA medium was used as a negative control. Light emis-
sion from each well was calculated relative to the total response
(ligand + Triton X-100) using the output file of Mikrowin2000
software (Mikrotek Laborsysteme, Overath, Germany). Further
analysis was done in GRAPHPAD PRISM 5 (GRAPHPAD software).
Cotransfected HEK293 cells were detached and counted as
described for the CHO cells, and next resuspended to a concen-
tration of 106 cells/ml in DMEM/F12 medium containing 200 μM
3-isobutyl-1-methylxanthine (IBMX, Sigma-Aldrich). In each well
of a 96-well plate, 50 μl of the cell suspension was dispensed
together with 50 μl of a pharmacological ligand dissolved in
DMEM/F12 medium containing 200 μM IBMX. The water-soluble
analogue of forskolin, NKH-477, was added to 20 μM concentra-
tions when inhibitory effects on intracellular cAMP were meas-
ured. After incubation for 3–4 h in a CO2 incubator at 37 °C, 100
μl of SteadyLite Plus (Perkin-Elmer, Boston, MA, USA) was
added to each well and the plate was gently shaken for 15 min in
the dark. Light emission resulting from the luciferase activity was
measured for 5 s per well using a Mithras LB940 Microplate
Reader (Berthold Technologies). Medium containing IBMX was
used as a negative control. Data were analysed as described for
CHO cells.
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